Recursion Pharmaceuticals News - October 6, 2026
🔴 Recursion Pharmaceuticals is trading at 4.7% down today alongside biotech ETF XBI's 2.50% decline
Recursion Pharmaceuticals is trading 4.7% lower at $4.55, with biotech-sector weakness a possible backdrop. - Biotech ETF XBI is down 2.50%; no clear...
Recursion's Tempus Deal Shrinks Its Cash Outflows and Licenses Its AI — But Can a $12 Million Side Deal Justify a 26% Weekly Rally?
Shares of Recursion Pharmaceuticals surged +6.3% to $5.08 on October 6, extending a blistering weekly run from $4.03 to over five dollars — a roughly 26% gain...
🟢 Recursion Pharmaceuticals jumps 6.3% with Cathie Wood's ARK Invest loading up shares, building on Tempus AI partnership optimism
Recursion Pharmaceuticals is trading at $5.08, up +6.28%, driven by fresh investment from Cathie Wood's ARK Invest and sustained optimism surrounding its...